Showing results (251-260 of 301) with videos related to

Sort By:
Pageof 31
Ophthalmic Plastic and Reconstructive Surgery|November 22, 2024
Quality of Life in Patients With Acquired Anophthalmia Using an Ocular ProsthesisElana Meer, Amanda C Miller, Meleha Ahmad, et al.
Investigational New Drugs|August 1, 1991
Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinomaJ A Ajani, R Pazdur, R J Winn, et al.
Cancer Treatment Reports|November 1, 1985
Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancerS P Leitner, E S Casper, T B Hakes, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 3, 2025
Quality of Life in Patients With Acquired Anophthalmia Using an Ocular ProsthesisElana Meer, Amanda C Miller, Meleha Ahmad, et al.
International Immunology|July 1, 1994
Peripheral lymphoid development and function in TCR mutant miceP Mombaerts, E Mizoguchi, H G Ljunggren, et al.
Chembiochem : a European Journal of Chemical Biology|January 25, 2018
Fine Tuning of Antibiotic Activity by a Tailoring Hydroxylase in a Trans-AT Polyketide Synthase PathwayHadi H Mohammad, Jack A Connolly, Zhongshu Song, et al.
Investigative Ophthalmology & Visual Science|April 19, 2008
Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhageRobert B Bhisitkul, Bryan J Winn, On-Tat Lee, et al.
Investigational New Drugs|July 30, 1999
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinomaR Pazdur, D C Medgyesy, R J Winn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical OncologyC L Bennett, T J Smith, J C Weeks, et al.
Investigational New Drugs|November 1, 1992
Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinomaF V Fossella, R J Winn, P Y Holoye, et al.
Pageof 31